Kintara Therapeutics
Stock Forecast, Prediction & Price Target

Kintara Therapeutics Financial Estimates

Kintara Therapeutics Revenue Estimates

Kintara Therapeutics EBITDA Estimates

Kintara Therapeutics Earnings per Share Estimates

Passed Analyst forecast
Metric 6/30/2022 6/30/2023 6/30/2024 6/30/2026 6/30/2027 6/30/2028
Revenue
 
% change YoY
$0
 
N/A
$0
 
0%
$0
 
0%
Avg: $99.15M
Low: $99.15M
High: $99.15M
avg. 0%
Avg: $7.41M
Low: $7.41M
High: $7.41M
avg. -92.51%
Avg: $21.01M
Low: $21.01M
High: $21.01M
avg. 183.34%
Net Income
 
% change YoY
$-22.61M
 
N/A
$-14.64M
 
35.23%
$-8.50M
 
41.96%
Avg: $-1.05M
Low: $-1.05M
High: $-1.05M
avg. 87.61%
Avg: $-1.00M
Low: $-1.00M
High: $-1.00M
avg. 4.61%
Avg: $-972K
Low: $-972K
High: $-972K
avg. 3.22%
EBITDA
 
% change YoY
$-22.62M
 
N/A
$-14.73M
 
34.88%
$-8.39M
 
43.02%
Avg: $0
Low: $0
High: $0
avg. 100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
EPS
 
% change YoY
-$23.22
 
N/A
-$9.04
 
61.06%
-$3.23
 
64.26%
Avg: -$0.65
Low: -$0.65
High: -$0.65
avg. 79.87%
Avg: -$0.62
Low: -$0.62
High: -$0.62
avg. 4.61%
Avg: -$0.6
Low: -$0.6
High: -$0.6
avg. 3.22%
Operating Expenses
 
% change YoY
$22.68M
 
N/A
$14.79M
 
-34.76%
$8.45M
 
-42.88%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%

FAQ

What is Kintara Therapeutics stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 31.81% in 2026-2028.

We have gathered data from N/A analysts. Their low estimate is -1.05M, average is -1.05M and high is -1.05M.

What is Kintara Therapeutics stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 30.27% in 2026-2028.

We have gathered data from N/A analysts. Their low revenue estimate is $99.15M, average is $99.15M and high is $99.15M.

What is Kintara Therapeutics stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 29.23% in 2026-2028.

We have gathered data from N/A analysts. Their low earnings per share estimate is -$0.65, average is -$0.65 and high is $-0.65.